[Federal Register Volume 68, Number 169 (Tuesday, September 2, 2003)]
[Notices]
[Pages 52226-52227]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-22323]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated may 2, 2003, and published in the Federal Register 
on May 29, 2003, (68 FR 32089), Roche Diagnostics corporation, Attn: 
Regulatory Compliance, 9115 Hague Road, Indianapolis, Indiana 46250, 
made application by renewal to the Drug Enforcement Administration to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                     Drug                               Schedule
------------------------------------------------------------------------
Lysergic Acid Diethylamide (7515)............  I
Tetrahydrocannabinol (7370)..................  I
Alphamethadol (9605).........................  I
Phencyclidine (7471).........................  II
Benzoylecogonine (9180)......................  II
Methadone (9250).............................  II
Morphine (9300)..............................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of controlled 
substances for use in diagnostic products.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Rocke Diagnostics

[[Page 52227]]

Corporation to manufacture the listed controlled substances is 
consistent with the public interested at this time. DEA has 
investigated Roche Diagnostics Corporation to insure that the company's 
registration is consistent with the public interest. This investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
in granted.

    Dated: August 19, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration
[FR Doc. 03-22323 Filed 8-29-03; 8:45 am]
BILLING CODE 4410-09-M